Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
CONCLUSIONS: This is the largest single center experience demonstrating incidence of EAD and identifying factors associated with development of EAD. EAD is a useful intermediate outcome measure for allograft and patient survival. Balancing recipient pretransplant conditions, donor risk factors and intra-operative conditions are necessary for avoiding EAD.
PMID: 31320168 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Bilirubin | Bone Graft | Gastroenterology | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology